A new drug to treat Type 2 diabetes has been launched in the UK.
Vildagliptin, which comes in tablet form and is taken once or twice a day, is part of a class of drugs that we featured on our website last year called DPP-4 (dipeptidyl peptidase-4) inhibitors.
How it works
DPP-4 inhibitors work by blocking the action of DPP-4, an enzyme which destroys the hormone incretin, and in doing so allows incretin levels to remain higher for longer.
Incretins are vital because they help the body produce more insulin when it is needed, and reduce the amount of glucose being produced by the liver when it is not needed. These hormones are released throughout the day and levels are increased at meal times.
The drug can be taken in conjunction with a number of other treatments. Ask your healthcare team for more information, or contact Novartis on 01276 692 255.